Eubacterium limosum modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis

IntroductionInflammatory bowel disease (IBD) is a chronic inflammatory condition of the intestine, for which no cure currently exists. The gut microbiota play a critical role in ameliorating IBD, and Eubacterium limosum has emerged as a potential probiotic with anti-inflammatory properties. However,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yao Lu, Huijing Tang, Qianhua Fan, Ruiting Lan, Xiaoying Lin, Shuwei Zhang, Liyun Liu, Jianguo Xu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-12-01
Colecção:	Frontiers in Immunology
Assuntos:	Eubacterium limosum gut microbiota colitis IL-17 signaling metabolites
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1728808/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!